Research Article
Anti-Platelet Factor 4/Heparin Antibody Formation Occurs Endogenously and at Unexpected High Frequency in Polycythemia Vera
Table 4
Characterization of anti-PF4/heparin antibody formation in MPN. A cohort of 127 patients with myeloproliferative neoplasms (MPN) including polycythemia vera (PV, ) and essential thrombocythemia (ET, ) were characterized for anti-PF4/heparin antibodies. Analysis by a screening ELISA was subsequently validated by follow-up testing and antibody isotype testing determining IgG, IgM, and IgA. PF4: platelet factor 4; Ig: immunoglobulin.
|